Income Taxes	9 Months Ended
Mar. 30, 2014
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company must recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. As of March 30, 2014, the Company's other long-term liabilities account includes $31.7 million of unrecognized tax benefits of which approximately $15.3 million would favorably impact its effective income tax rate in future periods if the Company's positions on these tax matters are upheld. The Company's policy is to recognize interest and/or penalties related to income tax matters in income tax expense. Included in the liability for unrecognized tax benefits was $2.5 million accrued for interest at March 30, 2014. The Company's effective income tax rates for the third quarter and the first nine months of fiscal year 2014 were 21.00% and 23.79%, respectively, as compared to 12.75% and 22.39%, respectively, in the same periods of fiscal year 2013. The increase in the effective income tax rates from the prior year periods was primarily due to the reinstatement during the third quarter of fiscal 2013 of the Federal Research and Development Tax Credit (“R&D Tax Credit”) that had expired December 31, 2011. As a result of reinstatement, during the third quarter of fiscal 2013 the Company adjusted its effective income tax rate for a full year’s R&D Tax Credit and recorded a discrete tax benefit for the prior fiscal year 2012 R&D Tax Credit. The R&D Tax Credit legislation expired once again effective December 31, 2013. Accordingly, the annual effective tax rate for fiscal 2014 includes the benefit of the R&D Tax Credit for six months whereas fiscal year 2013 included a full year’s tax benefit. In addition, the effective tax rates for each of the quarterly periods were favorably impacted by certain discrete tax benefits, primarily from the release of unrecognized tax benefits attributable to tax periods no longer subject to audit. The release of these tax benefits in fiscal 2013 had a greater impact on the effective tax rate recognized for the fiscal third quarter of 2013 as compared to the same period of fiscal 2014.

Income Taxes

The Company must recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. As of March 30, 2014, the Company's other long-term liabilities account includes $31.7 million of unrecognized tax benefits of which approximately $15.3 million would favorably impact its effective income tax rate in future periods if the Company's positions on these tax matters are upheld. The Company's policy is to recognize interest and/or penalties related to income tax matters in income tax expense. Included in the liability for unrecognized tax benefits was $2.5 million accrued for interest at March 30, 2014.

The Company's effective income tax rates for the third quarter and the first nine months of fiscal year 2014 were 21.00% and 23.79%, respectively, as compared to 12.75% and 22.39%, respectively, in the same periods of fiscal year 2013. The increase in the effective income tax rates from the prior year periods was primarily due to the reinstatement during the third quarter of fiscal 2013 of the Federal Research and Development Tax Credit (“R&D Tax Credit”) that had expired December 31, 2011. As a result of reinstatement, during the third quarter of fiscal 2013 the Company adjusted its effective income tax rate for a full year’s R&D Tax Credit and recorded a discrete tax benefit for the prior fiscal year 2012 R&D Tax Credit. The R&D Tax Credit legislation expired once again effective December 31, 2013. Accordingly, the annual effective tax rate for fiscal 2014 includes the benefit of the R&D Tax Credit for six months whereas fiscal year 2013 included a full year’s tax benefit. In addition, the effective tax rates for each of the quarterly periods were favorably impacted by certain discrete tax benefits, primarily from the release of unrecognized tax benefits attributable to tax periods no longer subject to audit. The release of these tax benefits in fiscal 2013 had a greater impact on the effective tax rate recognized for the fiscal third quarter of 2013 as compared to the same period of fiscal 2014.